Your browser doesn't support javascript.
loading
Efficacy and safety of aflibercept plus chemotherapy in metastatic colorectal cancer: A systematic review and PRISMA-Compliant single-arm Meta-Analysis of noncomparative clinical studies and randomized controlled trials.
Ge, Pu; Reyila, Abudurosuli; Li, Xin-Yi; Liu, Si-Yu; Jiang, Yi-Xuan; Yang, Ya-Jie; Li, Xia-Lei; Bian, Ying.
Afiliación
  • Ge P; Institute of Chinese Medical Sciences, University of Macau, Macau, China.
  • Reyila A; State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macau, China.
  • Li XY; Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Macau, China.
  • Liu SY; Xijing Hospital of Air Force Military Medical University, Xi'an, China.
  • Jiang YX; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Yang YJ; Stomatology College of Shandong University, Jinan, China.
  • Li XL; Institute of Chinese Medical Sciences, University of Macau, Macau, China.
  • Bian Y; State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macau, China.
J Clin Pharm Ther ; 47(6): 798-808, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35229901

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China